Literature DB >> 2547014

Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.

U Bergmann1, J Michaelis, R Oberhoff, V Knäuper, R Beckmann, H Tschesche.   

Abstract

A competitive and a sandwich enzyme linked immunosorbent assay (ELISA) were developed for human leukocyte collagenase and gelatinase. The competitive assay could detect 0.5 ng collagenase and 0.05 ng gelatinase. The detection limit of the sandwich ELISA was 0.05 ng for collagenase and 0.02 ng for gelatinase. No cross reactivity between human leukocyte collagenase and gelatinase was detected. The sandwich ELISA was used to determine plasma levels of these enzymes. The 90% range for collagenase was between 0 and 50 micrograms/l; the 90% range for gelatinase was between 27 and 94 micrograms/l.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547014     DOI: 10.1515/cclm.1989.27.6.351

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  13 in total

1.  Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.

Authors:  F Ratjen; C-M Hartog; K Paul; J Wermelt; J Braun
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

2.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

Authors:  S Lacraz; L P Nicod; R Chicheportiche; H G Welgus; J M Dayer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

4.  Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis.

Authors:  A Lauhio; Y T Konttinen; H Tschesche; D Nordström; T Salo; J Lähdevirta; L M Golub; T Sorsa
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.

Authors:  S Lacraz; L Nicod; B Galve-de Rochemonteix; C Baumberger; J M Dayer; H G Welgus
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis.

Authors:  A Lauhio; T Salo; Y Ding; Y T Konttinen; D Nordström; H Tschesche; J Lähdevirta; L M Golub; T Sorsa
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

7.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

8.  Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases.

Authors:  I Sopata; J Wize; A Filipowicz-Sosnowska; E Stanisławska-Biernat; B Brzezińska; S Maśliński
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Direct activation of human neutrophil procollagenase by recombinant stromelysin.

Authors:  V Knäuper; S M Wilhelm; P K Seperack; Y A DeClerck; K E Langley; A Osthues; H Tschesche
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

Review 10.  Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.

Authors:  Saif Mashaqi; Heidi M Mansour; Hanan Alameddin; Daniel Combs; Salma Patel; Lauren Estep; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.